In Vivo Pharmacodynamic Evaluation of B-luc Hep 3B plus Cells Induced Liver Cancer Models (CAT#: STEM-AE-0655-LGZ)

Introduction

Cancer type: Liver cancer<br />Cell line: B-luc Hep 3B plus<br />Clone: Single clone<br />Inoculation: Orthotopic

Principle Applications Procedure Materials Notes Related Products

Principle

By seeding tumor cells at organ-specific sites of the original tumor, in situ models simulate the initial lesion and establish better tumor, stroma, and immune component interactions than subcutaneous implants.

Applications

Liver Cancer

Procedure

1. Disease model construction.
2. Mice dosing.
3. Efficacy monitoring.
4. Biochemical detection of tissue samples.

Materials

• Sample Type: liquid or powder

Other recommended products

In Vivo Pharmacodynamic Evaluation of B-hPD-L1/hTIGIT Mice (Immune Checkpoint Humanized Mice) (CAT#: STEM-AE-0266-LGZ)
In Vivo Pharmacodynamic Evaluation of B-hCEACAM1 Mice (Immune Checkpoint Humanized Mice) (CAT#: STEM-AE-0227-LGZ)
In Vivo Pharmacodynamic Evaluation of B-hSELE/hSELL Mice (Immune Checkpoint Humanized Mice) (CAT#: STEM-AE-0275-LGZ)
In Vivo Pharmacodynamic Evaluation of B-hMIF Mice (Cytokine Humanized Mice) (CAT#: STEM-AE-0432-LGZ)
In Vivo Pharmacodynamic Evaluation of B-hCD70 Mice (Immune Checkpoint Humanized Mice) (CAT#: STEM-AE-0191-LGZ)
In Vivo Pharmacodynamic Evaluation of B-hALCAM Mice (Immune Checkpoint Humanized Mice) (CAT#: STEM-AE-0360-LGZ)
In Vivo Pharmacodynamic Evaluation of B-hCTLA4/hTIM3 Mice (Immune Checkpoint Humanized Mice) (CAT#: STEM-AE-0387-LGZ)
In Vivo Pharmacodynamic Evaluation of B-hC1Q Mice (Cytokine Humanized Mice) (CAT#: STEM-AE-0511-LGZ)